GENITAL NEOPLASMS, FEMALE

Clinical trials for GENITAL NEOPLASMS, FEMALE explained in plain language.

Never miss a new study

Get alerted when new GENITAL NEOPLASMS, FEMALE trials appear

Sign up with your email to follow new studies for GENITAL NEOPLASMS, FEMALE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New pill targets Cancer's genetic weakness in first human trial

Disease control Ongoing

This is a first-in-human study to find a safe dose and see how the body processes a new oral drug called ATV-1601. It is being tested in adults with advanced solid tumors, including certain breast cancers, that have a specific genetic change called an AKT1 E17K mutation. The main…

Matched conditions: GENITAL NEOPLASMS, FEMALE

Phase: PHASE1 • Sponsor: Atavistik Bio, Inc • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

GENITAL NEOPLASMS, FEMALE

Get alerted when new GENITAL NEOPLASMS, FEMALE trials appear

New pill targets Cancer's genetic weakness in first human trial